Mind Medicine Inc’s recent filing unveils that its Chief Executive Officer Barrow Robert unloaded Company’s shares for reported $0.14 million on Mar 25 ’25. In the deal valued at $6.74 per share,21,208 shares were sold. As a result of this transaction, Barrow Robert now holds 856,556 shares worth roughly $4.75 million.
Then, Karlin Daniel sold 6,836 shares, generating $46,075 in total proceeds. Upon selling the shares at $6.74, the Chief Medical Officer now owns 446,177 shares.
Before that, Sullivan Mark sold 6,576 shares. Mind Medicine Inc shares valued at $44,322 were divested by the Chief Legal Officer at a price of $6.74 per share. As a result of the transaction, Sullivan Mark now holds 316,621 shares, worth roughly $1.76 million.
Evercore ISI initiated its Mind Medicine Inc [MNMD] rating to an Outperform in a research note published on January 28, 2025; the price target was $23. A number of analysts have revised their coverage, including Chardan Capital Markets’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. ROTH MKM started covering the stock on July 24, 2024. It rated MNMD as “a Buy”.
Price Performance Review of MNMD
On Monday, Mind Medicine Inc [NASDAQ:MNMD] saw its stock jump 2.21% to $5.55. Over the last five days, the stock has gained 2.21%. Mind Medicine Inc shares have fallen nearly -20.26% since the year began. Nevertheless, the stocks have fallen -45.85% over the past one year. While a 52-week high of $10.47 was reached on 02/14/25, a 52-week low of $4.70 was recorded on 04/09/25. SMA at 50 days reached $6.85, while 200 days put it at $6.92.
Levels Of Support And Resistance For MNMD Stock
The 24-hour chart illustrates a support level at 5.34, which if violated will result in even more drops to 5.12. On the upside, there is a resistance level at 5.81. A further resistance level may holdings at 6.06. The Relative Strength Index (RSI) on the 14-day chart is 43.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.32, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 60.09%. Stochastics %K at 30.25% indicates the stock is a holding.
How much short interest is there in Mind Medicine Inc?
A steep rise in short interest was recorded in Mind Medicine Inc stocks on 2025-03-31, dropping by -0.47 million shares to a total of 11.34 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 11.81 million shares. There was a decline of -4.13%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 29, 2024 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $27 price target.
